Spots Global Cancer Trial Database for Feasibility of a Molecular Characterisation Approach to Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Feasibility of a Molecular Characterisation Approach to Treatment
Official Title: FOrMAT - Feasibility of a Molecular Characterisation Approach to Treatment
Study ID: NCT02112357
Conditions
Interventions
Study Description
Brief Summary: This study will assess the feasibility of sequencing locally advanced/metastatic gastrointestinal cancers in real-time to enable future treatment stratification by molecular characteristics. Targeted next generation sequencing of a panel of genes will be performed on tumour specimens and results will be discussed at a Sequencing Tumour Board to establish if a patient is potentially suitable for a targeted therapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Royal Marsden NHS Foundation Trust, London and Surrey, , United Kingdom
Contact Details
Name: Dr. Naureen Starling, BSc, MBBS, MRCP
Affiliation: Royal Marsden NHS Foundation Trust
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
